Recipient mice that received TCF7-SPI1 + NRAS(G12D) developed leukemia (median disease-free survival = 66 days) with a similar latency to those that received NRAS(G12D) alone (median disease-free survival = 74 days). Here, TCF7 is linked to leukemia.